CARDIFF-BY-THE-SEA, CA, Field Medical, a clinical-stage company redefining cardiac ablation, announced the close of a $35 million Series B financing round.
Field Medical, a clinical-stage company redefining cardiac ablation with next-generation pulsed field ablation (PFA) technology, announced the close of a $35 million Series B financing round co-led by BioStar Capital and Cue Growth, with participation from existing strategic investors.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
